ChemicalBook > Product Catalog >Pharmaceutical intermediates >Bulk Drug Intermediates >4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid

4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid

4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid Structure
CAS No.
641569-94-0
Chemical Name:
4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid
Synonyms
-3-((4-(pyridin-3-yL;Nilotinib Intemediate 2;Nilotinib EP Impurity D;Nilotinib EP Impurity D/B;4-Methyl-3-((4-(pyridin-3-yl);Nilotinib Carboxylic Acid Impurity;Nilotinib Impurity 6 (Nilotinib EP Impurity D);Nilotinib Hydrochloride Monohydrate EP Impurity D;4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]benzoicaci;4-Methyl-3-[[4-(3-pyridinyl)-2-pyriMidiny]aMino]benzoic acid
CBNumber:
CB61503982
Molecular Formula:
C17H14N4O2
Molecular Weight:
306.32
MOL File:
641569-94-0.mol
MSDS File:
SDS
Modify Date:
2024/4/28 19:50:54

4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid Properties

Melting point >257oC (dec.)
Boiling point 587.9±60.0 °C(Predicted)
Density 1.336
storage temp. under inert gas (nitrogen or Argon) at 2–8 °C
solubility DMSO (Slightly), Methanol (Slightly, Heated)
pka 4.35±0.10(Predicted)
form Solid
color Pale Beige
Stability Hygroscopic
InChI InChI=1S/C17H14N4O2/c1-11-4-5-12(16(22)23)9-15(11)21-17-19-8-6-14(20-17)13-3-2-7-18-10-13/h2-10H,1H3,(H,22,23)(H,19,20,21)
InChIKey LDLZPHLSVKGFSC-UHFFFAOYSA-N
SMILES C(O)(=O)C1=CC=C(C)C(NC2=NC=CC(C3=CC=CN=C3)=N2)=C1
CAS DataBase Reference 641569-94-0(CAS DataBase Reference)

SAFETY

Risk and Safety Statements

Symbol(GHS) 
GHS07
Signal word  Warning
Hazard statements  H302+H312+H332-H315-H319-H335
Precautionary statements  P261-P271-P280
HS Code  2933599590

4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid Chemical Properties,Uses,Production

Uses

4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid is used in the preparation of (pyridinyl)-N-[(triazolyl)phenyl]pyrimidinamine derivatives and (pyridinyl)-N-[oxadiazolyl)phenyl]pyrimidinamine derivatives, and can be used in the detection of their activity as antileukemia agents (neoplastic stem cell leukemia). 4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid is also a Nilotinib (N465300) intermediate, which might be useful in treatment of chronic myelogenous leukemia.

Synthesis

3- [(Aminoiminomethyl)amino] -4-methyl-benzoic acid methyl ester mononitrate (10 g),3-(Dimethylamino)-1-(pyridine-3-yl)prop-2-en-1-one (7.3 g), sodium hydroxide (1.7 g) was added to 1-butanol (100 mL) in a round bottom flask under nitrogen atmosphere. The reaction mass was heated to reflux temperature and stirred for 12 hours. Then the reaction mass was cooled to 25-35°C, and iN sodium hydroxide solution (1.5 g in 37 mL of DM water) was added to it throughout 20 mm. The reaction mass was heated to reflux temperature (120-125°C) and then cooled to 25-35°C. Hydrochloric acid was added to the reaction mass at 25-35°C and stirred for an hour. The material formed was filtered, washed with DM water and then dried under vacuum at 50-55°C to provide 4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid (8.7 g).

Global( 256)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
Urantiis Pharmaceuticals Private Limited +918790703567 AndhraPradesh, India 80 58 Inquiry
Rampex Labs Private Limited +91 9168074433 Telangana, India 71 58 Inquiry
Litha Life Sciences Pvt Limited +91-9849999500 +91-9849999500 Hyderabad, India 29 58 Inquiry
Credas Labs Pvt Ltd +91 9133918031 Hyderabad, India 119 58 Inquiry
TRC FINE CHEMS +91-7400278327 +91-8097105248 Mumbai, India 73 58 Inquiry
Lorven therapeutics Pvt Ltd +91-8884110005 +91-8884110005 Hyderabad, India 110 58 Inquiry
VGS SYNTHESIS PRIVATE LIMITED +91-9866975588 +91-9866975588 Hyderabad, India 1818 58 Inquiry
Raising Sun Pharma +91-9399941155 +91-9399941155 Telangana, India 127 58 Inquiry
Lakshmi Farmachem +91-9948795885 +91-9550886476 Telangana, India 407 58 Inquiry
Accrete Pharmaceuticals Private Limited +91-9246370012 +91-9246370012 Hyderabad, India 24 58 Inquiry
4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid 4-Methyl-3-{[4-(pyridin-3-yl)pyrimidin-2-yl]amino}benzoic acid Benzoic acid, 4-Methyl-3-[[4-(3-pyridinyl)-2-pyriMidinyl]aMino]- 4-Methyl-3-[[4-(3-pyridinyl)-2-pyriMidiny]aMino]benzoic acid 2-[(5-Carboxy-2-methylphenyl)amino]-4-(pyridin-3-yl)pyrimidine, 3-{2-[(5-Carboxy-2-methylphenyl)amino]pyrimidin-4-yl}pyridine Nilotinib Intemediate 2 4-Methyl-3-((4-(pyridin-3-yl) Nilotinib EP Impurity D Nilotinib Carboxylic Acid Impurity -3-((4-(pyridin-3-yL 4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid(For export only) Nilotinib EP Impurity D/B 4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic aci... 3-(4-(pyridin-3-yl)pyrimidin-2-ylamino)-4-methylbenzoic acid 4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]benzoicaci Nilotinib Impurity 6 (Nilotinib EP Impurity D) Nilotinib Hydrochloride Monohydrate EP Impurity D 4-Methyl-3-[[4-G-pyridinyl)-2-pyrimidinyl]amino] benzoic acid 641569-94-0 641589-94-0